Han Jae Sang, Kim Yeonji, Park Moo Kyun, Song Jae-Jun, Moon Il Joon, Lee Woojoo, Cho Young Sang, Seo Jae-Hyun, Park Yong-Ho
Department of Otolaryngology-Head and Neck Surgery, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
PLoS One. 2022 May 26;17(5):e0269123. doi: 10.1371/journal.pone.0269123. eCollection 2022.
The objective of this study was to investigate current perception and expected price of personal sound amplification products (PSAPs) and to analyze influencing factors through multi-center hospital-based surveys of outpatients, caregivers, and hearing experts.
A multi-center exploratory cross-sectional study was conducted in two groups of respondents with two separate surveys: 1) a perception survey of patients and caregivers who visited an otorhinolaryngology outpatient clinic in 5 general hospitals and 2) an opinion survey of hearing specialists about the expected price of PSAPs. A total of 197 outpatient visitors responded to the perception survey, and 42 hearing specialists responded to the opinion survey.
Overall perception score (18 questions) was 3.04 (95% CI, 3.00-3.09). When 5 categories of perception (knowledge, needs, cost, expectation, and information categories) were analyzed, cost and expectation showed the highest scores of 3.33 (95% CI, 3.21-3.44) and 3.33 (95% CI, 3.27-3.40), respectively, and needs showed the lowest score of 2.23 (95% CI, 1.97-2.49). The ≥ 60-year-old group showed significantly higher perception of PSAPs (P = 0.002), and the individuals with greater severity of subjective hearing loss showed significantly higher perception of PSAPs (P = 0.002). The expected price of PSAPs of the outpatient visitors was 933.9 USD (95% CI, 811.9-1056.0) per ear. Mean expected price of PSAPs of hearing specialists was 291.3 USD (95% CI, 238.2-344.3) per ear.
The perception rate of PSAPs was very low, and there was a discrepancy in the expected price of PSAPs between patients/caregivers and hearing experts. Hearing specialists should make effort to improve perception of PSAPs.
本研究的目的是调查个人扩音产品(PSAP)的当前认知度和预期价格,并通过对门诊患者、护理人员和听力专家进行多中心医院调查来分析影响因素。
在两组受访者中进行了一项多中心探索性横断面研究,采用两项独立调查:1)对5家综合医院耳鼻喉科门诊就诊的患者和护理人员进行认知度调查;2)对听力专家进行关于PSAP预期价格的意见调查。共有197名门诊就诊者对认知度调查做出了回应,42名听力专家对意见调查做出了回应。
总体认知度得分(18个问题)为3.04(95%置信区间,3.00 - 3.09)。当对认知度的5个类别(知识、需求、成本、期望和信息类别)进行分析时,成本和期望得分最高,分别为3.33(95%置信区间,3.21 - 3.44)和3.33(95%置信区间,3.27 - 3.40),需求得分最低,为2.23(95%置信区间,1.97 - 2.49)。≥60岁组对PSAP的认知度显著更高(P = 0.002),主观听力损失程度更严重的个体对PSAP的认知度显著更高(P = 0.002)。门诊就诊者对PSAP的预期价格为每只耳朵933.9美元(95%置信区间,811.9 - 1056.0)。听力专家对PSAP的平均预期价格为每只耳朵291.3美元(95%置信区间,238.2 - 344.3)。
PSAP的认知率非常低,患者/护理人员与听力专家对PSAP的预期价格存在差异。听力专家应努力提高对PSAP的认知度。